Key Points

• Continued increase, albeit more moderate than in previous years, in vaccination uptake among infants covered by the expanded vaccination mandate:

  • +1 percentage point in vaccination coverage for the second dose of the measles, mumps, and rubella (MMR) vaccine at 33 months of age between the 2019 and 2020 cohorts (2018 cohort: 83.8%; 2019 cohort: 84.7%; 2020 cohort: 85.7%),

  • +0.3 percentage points for vaccination coverage of the third dose of the vaccine against diphtheria, tetanus, polio, pertussis, Haemophilus influenzae type b, and hepatitis B at 21 months of age between the 2020 and 2021 cohorts (2019 cohort: 90.5%; 2020 cohort: 90.9%; 2021 cohort: 91.2%),

• Increase in vaccination coverage among children and adolescents not subject to mandatory vaccination:

  • Between +1.1 and +4.3 percentage points increase in vaccination coverage between 2021 and 2022 for catch-up vaccination against meningococcal C in all age groups over 4 years of age,

  • For the HPV vaccine in young girls:

    • +4.1 percentage points for the vaccination coverage of the second dose among 16-year-old girls born in 2006 (41.5%) compared to that of girls born in 2005 (37.4%),

    • +2.0 percentage points for first-dose HPV vaccination coverage among 15-year-old girls (2007 cohort: 47.8%, 2006 cohort: 45.8%): continued progress but with a trend toward stabilization (+5.2 percentage points increase in previous years (2006 and 2005 cohorts), even though vaccination coverage remains insufficient,

• Vaccination coverage of at least one dose against Meningococcal B at 8 months stands at 48.8% (2022 cohort), for this vaccination recommended since June 2022.

• Increased vaccination uptake in the general population since 2019 in mainland France, reaching 84.6% in 2022.

However,

• Low vaccination coverage against HPV infections among young boys (12.8% for the first dose at age 15, 8.5% for the second dose at age 16), for this vaccine introduced in 2021.

• Insufficient influenza vaccination coverage (51.5%) among individuals with risk factors for severe influenza (compared to the target of 75%) and marked by social health inequalities.